A multi-centre long-term follow-up study of patients with low-grade non-Hodgkin's lymphoma previously treated with tositumomab and/or iodine I 131 tositumomab in studies RIT-I-000, RIT-II-001, RIT-II-002, or CP-97-012

Trial Profile

A multi-centre long-term follow-up study of patients with low-grade non-Hodgkin's lymphoma previously treated with tositumomab and/or iodine I 131 tositumomab in studies RIT-I-000, RIT-II-001, RIT-II-002, or CP-97-012

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2015

At a glance

  • Drugs Iodine-131 tositumomab; Tositumomab
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 09 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 31 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top